Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population

PURPOSEOver the past decade, there have been significant advancements in the treatment of AML. However, similar progress has not been observed in India, with induction mortality rates surpassing those in high-income countries. Our patient population also differs significantly from those in clinical...

Full description

Saved in:
Bibliographic Details
Main Authors: Hasmukh Jain, Thomas Eipe, Alok Shetty, Lingaraj Nayak, Bhausaheb Pandurang Bagal, Neha Sharma, Akash Pawar, Manju Sengar
Format: Article
Language:English
Published: American Society of Clinical Oncology 2025-04-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO-24-00482
Tags: Add Tag
No Tags, Be the first to tag this record!